NCT02645890View on ClinicalTrials.gov

Study to Compare the Safety and Pharmacokinetics of CKD-397

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

CKD-397

Arm A:Tamsulosin/ Tadalafil Fixed dose combination

DRUG

TD+TM

Arm B: Tamsulosin/ Tadalafil Coadministration

Trial Locations (1)

49201

Dong A University Hospital, Seo-gu

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY

NCT02645890 - Study to Compare the Safety and Pharmacokinetics of CKD-397 | Biotech Hunter | Biotech Hunter